A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB

resisttb
Aug 11, 2024
1 min read

Members of the resist TB team recently published an open access letter to the editor regarding the effectiveness of consilia. Please find the article here.

Recent Posts

See All

Open letter: Experts call for urgent expansion of Pretomanid label

Despite trials like TB-PRACTECAL displaying the efficacy of pretomanid in the expanded BPaLM regimen, the EMA only approved for the BPaL...

WHO Accelerator Platform for Novel TB Regimens

The meeting of the WHO Accelerator Platform for Novel TB Regimens will be held on Thursday, 8 May 2025, from 14.00 to 15.30 (CET). Main...

WHO announces landmark changes in treatment of drug-resistant tuberculosis

The WHO released comprehensive guidelines for TB this week and shared important new updates to treatment options for MDR-TB. In...

Comments